[HTML][HTML] The brain interstitial system: Anatomy, modeling, in vivo measurement, and applications

Y Lei, H Han, F Yuan, A Javeed, Y Zhao - Progress in neurobiology, 2017 - Elsevier
Although neurons attract the most attention in neurobiology, our current knowledge of neural
circuit can only partially explain the neurological and psychiatric conditions of the brain …

The neurochemical profile quantified by in vivo 1H NMR spectroscopy

JMN Duarte, H Lei, V Mlynárik, R Gruetter - Neuroimage, 2012 - Elsevier
Proton NMR spectroscopy is emerging from translational and preclinical neuroscience
research as an important tool for evidence based diagnosis and therapy monitoring. It …

Mitochondria as a therapeutic target for aging and neurodegenerative diseases

PH Reddy, TP Reddy - Current Alzheimer Research, 2011 - ingentaconnect.com
Mitochondria are cytoplasmic organelles responsible for life and death. Extensive evidence
from animal models, postmortem brain studies of and clinical studies of aging and …

Curcumin nanoparticles attenuate neurochemical and neurobehavioral deficits in experimental model of Huntington's disease

R Sandhir, A Yadav, A Mehrotra, A Sunkaria… - Neuromolecular …, 2014 - Springer
Till date, an exact causative pathway responsible for neurodegeneration in Huntington's
disease (HD) remains elusive; however, mitochondrial dysfunction appears to play an …

[HTML][HTML] Mutant huntingtin, abnormal mitochondrial dynamics, defective axonal transport of mitochondria, and selective synaptic degeneration in Huntington's disease

PH Reddy, UP Shirendeb - Biochimica et Biophysica Acta (BBA)-Molecular …, 2012 - Elsevier
Huntington's disease (HD) is a progressive, fatal neurodegenerative disease caused by
expanded polyglutamine repeats in the HD gene. HD is characterized by chorea, seizures …

Development, characterization and nasal delivery of rosmarinic acid-loaded solid lipid nanoparticles for the effective management of Huntington's disease

R Bhatt, D Singh, A Prakash, N Mishra - Drug delivery, 2015 - Taylor & Francis
Objective: The objective of the present study was to investigate the potential use of solid lipid
nanoparticles (SLNs) as a drug delivery system to enhance the brain-targeting efficiency of …

Mitochondrial structural and functional dynamics in Huntington's disease

PH Reddy, P Mao, M Manczak - Brain research reviews, 2009 - Elsevier
Huntington's disease (HD) is an autosomal, dominantly inherited neurodegenerative
disorder, characterized by chorea, involuntary movements, and cognitive impairments …

Lycopene prevents 3-nitropropionic acid-induced mitochondrial oxidative stress and dysfunctions in nervous system

R Sandhir, A Mehrotra, SS Kamboj - Neurochemistry International, 2010 - Elsevier
3-Nitropropionic acid (3-NP), an irreversible inhibitor of succinic acid dehydrogenase (SDH),
induces neurodegeneration similar to that observed in Huntington's disease (HD). The …

Mitochondria and the brain: bioenergetics and beyond

P Belenguer, JMN Duarte, PF Schuck… - Neurotoxicity research, 2019 - Springer
The view of mitochondria acting solely as a powerhouse of the cell is no longer accurate.
Besides cell bioenergetics, primary targets of mitochondrial studies include their interplay …

Mitochondrial mechanisms of estrogen neuroprotection

JW Simpkins, JA Dykens - Brain research reviews, 2008 - Elsevier
Oxidative stress, bioenergetic failure and mitochondrial dysfunction are all implicated in the
etiology of neurodegenerative diseases such as Alzheimer's disease (AD). The …